Practical Insulin: A Handbook for Prescribing Providers
Autor Neumilleren Limba Engleză Paperback – 21 aug 2019
This indespensible handbook gives physicians, clinicians, and diabetes educators the information and data necessary to successfully initiate and maintain insulin therapy in people with type 1 and type 2 diabetes. Now, in its fifth edition, Practical Insulin is completely revised and updated to evaluate the changing landscape of insulin therapy. With this easy, fully indexed reference guide, you can make improved glycemic control an achievable reality for your patients.
Topics include:
--Available insulin products
--Delivery methods
--Injection regimens
--Barriers to efficacy
--Calculating total insulin dose, insulin-to-carbohydrate ratio, and correction doses
--Therapy for type 1 and type 2 diabetes
Preț: 60.75 lei
Preț vechi: 63.95 lei
-5% Nou
Puncte Express: 91
Preț estimativ în valută:
10.75€ • 12.52$ • 9.39£
10.75€ • 12.52$ • 9.39£
Carte disponibilă
Livrare economică 29 decembrie 25 - 12 ianuarie 26
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781580407359
ISBN-10: 1580407358
Pagini: 96
Dimensiuni: 152 x 224 x 5 mm
Greutate: 0.11 kg
Ediția:00005
Editura: American Diabetes Association
ISBN-10: 1580407358
Pagini: 96
Dimensiuni: 152 x 224 x 5 mm
Greutate: 0.11 kg
Ediția:00005
Editura: American Diabetes Association
Notă biografică
The American Diabetes Association, the largest diabetes-focused, not-for-profit organization in the world, is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
Descriere
This indispensable handbook gives physicians, clinicians, and diabetes educators the information and data necessary to successfully initiate and maintain insulin therapy in people with type 1 and type 2 diabetes. Now completely revised and updated to evaluate the changing landscape of insulin therapy.